CLINICAL_TRIALS
trial_result
· 2025-09-25
Clinical Trial Update: Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer [Phase 3]
Summary
A Phase 3 trial evaluating a treatment for refractory nausea and vomiting in breast cancer patients has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Rochester NCORP Research Base | Conditions: Breast Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2025-09-25